background: intravenous immunoglobulin (ivig) is an established treatment of immune mediated demyelinating neuropathy including guillain-barré syndrome and chronic inflammatory demyelinating polyneuropathy. recent trials suggest its efficacy in treating relapsing- remitting multiple sclerosis. ivig exerts a number of effects, which may be beneficial in treating multiple sclerosis (ms): reductio...

introduction: acute idiopathic thrombocytopenic purpura (itp) is an autoimmune bleeding disorder of childhood caused by production of auto antibodies against platelets. the aim of the present study was to compare the efficacy of intravenous immunoglobulin (ivig) and intravenous anti-d(iv anti-d) in itp treatment. methods and materials: in a clinical trial, 43 children with acute itp referred to...

long-term intravenous immunoglobulin (ivig) infusion is an effective treatment for children with humoral immunodeficiencies, already be complicated by systemic ad¬verse effects. in order to determine the adverse effects of intravenous immunoglobulin inpatients with antibody deficiency, 45 immunodeficientpatients receiving intravenous immunoglobulin were studied during a 36-month period at child...

background: the infection in the neonatal period is a significant cause of mortality in the preterm neonates. the transfer of the immunoglobulin from mother to fetus occurs mainly after 32 to 34 weeks of gestation. therefore, preterm neonates are relatively immune compromised. the aim of the study was to evaluate the impact of intravenous immunoglobulin on mortality rates reduction in preterm n...

Evaluation of the Neutrophil to Lymphocyte Ratio in Patients Kawasaki Disease Resistant Intravenous immunoglobulin (IVIg) Therapy

Two different cases of Stevens - Johnson syndrome are reported. We used intravenous immunoglobulin in their management and compared the results of treatment with the conventional lines of therapy in a historical control.